PO-1372 First institutional analysis between ultra vs moderate hypofractionated regimens in prostate cancer. (August 2021) - Ferraris, G.; Andrada, P.; Gomez Palacios, A.; Alvarado, L.; Eduardo, F.; Caussa, L.; Diego, F.; Maria Fernanda, D.V.